首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1733298

全球私人診所實驗室市場：市場規模（按產品、應用和地區分類）、未來預測

Global Office Based Lab Market Size By Product (Single-specialty OBL, Multi-specialty OBL, Hybrid), By Application (Vascular Surgery, Ophthalmology, Pain Management), By Geographic Scope And Forecast

出版日期: 2025年05月13日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

私人診所實驗室的市場規模與預測

2024 年基於醫生的實驗室市場規模價值 112 億美元，預計到 2032 年將達到 172 億美元，預測期內（2026-2032 年）的複合年成長率為 6.75%。

臨床環境中外科手術的上升趨勢和各種血管疾病的發生率上升正在推動全球基於醫生的實驗室市場的發展。推動全球市場擴張的其他關鍵方面是增加報銷、成本優勢和患者便利性。此外，人們對微創手術的偏好和採用日益增加，預計將打開全球市場。全球範圍內目標疾病盛行率的上升、對微創手術的偏好和採用的增加、以及醫生在為患者提供治療方面的自主性水平的提高都是影響基於醫生的實驗室市場的主要因素。私人診所實驗室順暢的業務流程和較高的患者滿意度可能會提供進一步的市場成長潛力。

定義全球私人診所實驗室市場

私人診所實驗室是配備各種醫療設備和技術的專科診所或醫生辦公室，為患者提供個人化護理。它也被稱為門診手術中心。它有助於在短暫的住院時間內提供快速治療。它使醫生能夠更好地控制患者，從而提高生產力和效率。全球目標疾病盛行率的上升、對微創手術的偏好和適應症的增加以及醫生在為患者群體提供治療方面的控制力和自主權的增強是影響基於醫生的實驗室市場成長的主要因素。

私人診所實驗室的順暢營運流程和較高的患者滿意度預計將為市場成長提供進一步的機會。以從業人員為基礎的實驗室市場依模式分為單一實驗室、多專業實驗室和混合實驗室。基於醫生的實驗室市場根據服務分為周邊血管護理、血管內護理、心臟病學、介入放射學、靜脈等。診斷測試、動脈粥狀硬化斑塊切除動脈粥狀硬化斑塊切除術、血栓切除術、栓塞治療、血管內超音波(IVUS)、血液透析機晶粒以及下腔靜脈過濾器的放置和移除都是血管內干預的例子。

血管成形術和支架置入術是兩種不同類型的心血管手術。靜脈手術包括靜脈消融、中心靜脈治療和深層靜脈栓塞症(DVT) 手術。心血管外科醫生、眼科醫生、疼痛管理醫師、胃腸病學家、經皮心臟科醫生、介入放射科醫生和骨科醫生是私人診所實驗室市場中的一些專家。 OBL 產業採用人工智慧對於技術創新至關重要，而由於人工智慧和機器人手術趨勢的變化，私人診所實驗室市場將顯著成長。因此，這是最近受到廣泛關注的重要領域。

全球私人診所實驗室市場概況

推動對 OBL 需求的主要促進因素之一是門診手術趨勢的增加以及各種血管疾病盛行率的上升。此外，預計該行業將蓬勃發展，患者滿意度高，專業團隊專注。許多服務供應商遍布全國，包括 Nationwide Cardiac Associates、Envision Healthcare 和 Surgery Partners，為患者提供低成本、基於醫生的手術產品和解決方案。

此外，飛利浦醫療、西門子赫茲等領先製造商也與醫生合作設立OBL，為他們的實驗室配備必要的設備，提供從頭到尾的全面解決方案。與醫院門診 (HO) 相比，OBL 的建立為醫生提供了支付方面的優勢。由於私人診所的實驗室為醫生提供豐厚的報銷，因此進行血管手術的費用較低。此外，預計該行業將蓬勃發展，患者滿意度高，專業團隊專注。全國有許多服務供應商，包括 National Cardiac Partners、Envision Health 和 Surgery Partners，為患者提供低成本、以醫生為基礎的手術服務和解決方案。

然而，OBL 在實施新技術時擔心的一個問題是報銷。醫療保險和醫療補助服務中心 (CMS) 為程序設定付款標準，保險公司遵循這些標準。此外，由於研發成本，新設備和技術價格昂貴。 OBL 的預算非常緊張，因為其在技術方面獲得的補償比醫院少。 OBL 要繼續經營，就無法負擔新設備的高昂成本。因此，核准用於門診病人的設備可能價格過高，並且未充分利用。

私人診所實驗室市場（按產品）

單一主體 OBL
多主體 OBL
混合
根據產品，市場細分為單一主題 OBL、多主題 OBL 和混合。雖然單一專業的 OBL 在 2018 年佔據了市場主導地位，但預計混合從業人員實驗室將在未來幾年快速成長。單一專業實驗室能夠提供更好的以患者為中心的護理，而混合實驗室則透過將不同的服務整合在同一屋簷下，從而提供更高的盈利。

私人診所實驗室市場（按應用）

血管外科
眼科
疼痛管理
胃腸病學
整形外科
其他
根據應用，市場分為血管外科、眼科、疼痛管理、胃腸病學、整形外科等。血管外科醫生是 OBL 中最常見的服務供應商，佔據了很大的市場佔有率。這可能是由於該國血管疾病負擔日益加重所致。血管外科醫師在私人診所進行所有主要的血管手術，包括主動脈、腸系膜、腎臟、鎖骨下、髂股、脛骨和腳部手術。

私人診所實驗室市場（按地區）

北美洲
歐洲
亞太地區
世界其他地區
根據地區，全球基於實踐的實驗室市場分為北美、歐洲、亞太地區和亞太其他地區。從服務來看，由於美國動脈硬化發病率不斷上升，周邊血管介入（PVI）佔據私人診所實驗室市場主導地位。此外，大量針對動脈和靜脈阻塞患者進行的球囊血管成形術和支架置入術也推動了這一領域的成長。美國近 70% 的外科手術是在門診進行的，約 25% 的外科手術是在醫生檢查室進行的。

主要企業

「全球私人診所實驗室市場」分析報告提供了有關 Envision Healthcare、TH Medical、MEDNAX Services, Inc、TeamHealth、Medical Facilities Corporation、Surgical Care Affiliates、QHCCS, LLC、Fresenius Medical Care AG &Co.KGaA、Surgery Partners、Medical Facilities Corporation 等公司的寶貴資訊。競爭格局部分還包括上述全球公司的關鍵發展策略、市場佔有率和市場排名分析。

主要進展

波士頓科學公司以 42 億美元收購英國微創設備製造商 BTG，將擴大其微創手術設備產品組合。兩家公司於 2018 年 11 月達成收購協議，波士頓科學公司預計此次收購將支持其患者照護策略。
豆蔻去年獲得 FDA核准後被聖猶達以 3.75 億美元收購。該設備的表面積只有回形針大小，它使用最初用於監測噴射引擎的嵌入式感測器來遠端監測心臟衰竭患者的肺動脈張力。聖猶達醫療公司致力於“基於創新的成長策略”，提供醫療設備，幫助醫生治療患有慢性心血管疾病的患者。
今年早些時候，波士頓科學公司收購了無線心臟監測設備製造商 Preventive Solutions 27% 的股份。根據協議，波士頓科學公司將成為 Preventive 心臟監測產品的全球行銷商和經銷商。

The growing trend of performing surgical techniques in clinical settings, as well as the rising frequency of various vascular illnesses, are driving the global Office Based Lab Market. Other major aspects driving global market expansion are higher reimbursements, expense advantages, and patient convenience. Furthermore, the global market is predicted to develop because of an increase in the inclination for and implementation of minimally invasive surgeries The rise in the prevalence of target diseases around the world, rising preferences for and adoption of minimally invasive surgeries, and increased levels of autonomy for doctors in providing therapies to their patients are all major factors that will influence the market for office-based labs. Smooth operational flow at office-based labs, as well as a high patient satisfaction rate, will give further market growth potential.

Global Office Based Lab Market Definition

Office-based labs are specialized clinics or physician offices that are outfitted with various medical devices and technologies in order to provide patients with personalized care. They are also known as ambulatory surgical centers. They are useful for providing swift treatments with a shorter stay time. They give physicians more control over their patients and, as a result, promote good productivity and efficiency. The rising incidence of target diseases globally, soaring preferences and adaptation of minimally invasive surgeries, and greater control and autonomy for doctors in supplying therapies to their patient populations are the major factors influencing the growth of the Office Based Lab Market.

A smooth operational flow at office-based labs and a high patient satisfaction rate will provide additional opportunities for market growth. The market for Office Based Lab is classified into single labs, multi-specialty labs, and hybrid labs based on modality. The Office Based Lab Market is divided as peripheral vascular treatment, endovascular treatments, cardiology, interventional radiology, venous, and other segments based on service. Diagnostic testing, atherectomy, thrombectomy, embolization, intravascular ultrasound (IVUS), hemodialysis access dicots, and IVC filter implantation and removal are all examples of endovascular interventions.

Angioplasty and stenting are two different types of cardiac procedures. Venous procedures include venous ablation, central venous treatments, and deep vein thrombosis (DVT) procedures. Cardiovascular surgeons, ophthalmology, pain control, gastro, percutaneous cardiologists, interventional radiologists, orthopedics, and others are among the specialists in the Office Based Lab Market. Artificial intelligence's adoption in the OBL industry is critical for innovation, as in the Office Based Lab Market there has been a significant increase because of artificial intelligence and the shift in the trend toward robotic surgery. Thus, it is a key area that has been given key attention lately.

Global Office Based Lab Market Overview

One of the key causes driving the desire for Office Based Lab (OBL) is the growing tendency of surgical operations to be conducted in outpatient settings, as well as the rising incidence of different vascular diseases. Furthermore, the industry is predicted to develop due to high patient satisfaction and a concentrated and dedicated team of experts. Many service providers, such as Nationwide Cardiac Associates, Envision Healthcare, and Surgery Partners, are located around the country and have been providing patients with low-cost office-based surgical products and solutions.

Moreover, major manufacturers such as Philips Healthcare and Siemens Healthineers have formed collaborations with physicians to set up OBLs, equip laboratories with necessary devices, and provide comprehensive solutions from start to finish, which is projected to drive market expansion. Establishing an OBL is advantageous for physicians in terms of payments as compared to hospital outpatient (HO) settings. Because of the substantial reimbursement offered to physicians, the cost of vascular operations conducted in office-based laboratories is lower. Furthermore, the industry is predicted to develop due to high patient satisfaction and a concentrated and dedicated team of experts. Many service providers, such as National Cardiac Partners, Envision Health, and Surgery Partners, are located around the country and have been offering patients low-cost office-based surgical services and solutions.

However, reimbursement is a concern for the OBL when it comes to new technology. The Centers for Medicare & Medicaid Services (CMS) sets a standard for procedure payments, and insurers follow suit. New equipment and technologies are also more expensive, owing to the costs of research and development. Because compensation for the technical element is lower for OBLs than for hospitals, they operate on a tighter budget. OBLs simply cannot afford the expensive costs of new devices in order to stay in business. As a result, equipment approved for outpatient usage may be prohibitively expensive and consequently underutilized.

Office Based Lab Market, By Product

Single-specialty OBL
Multi-specialty OBL
Hybrid
Based On Product, The Market is Segmented into Single-specialty OBL, Multi-specialty OBL, And Hybrid. Single specialty OBLs dominated the market in 2018, but hybrid office-based labs are expected to rise rapidly over the next few years. Single-specialty laboratories provide better patient-centered care, but hybrid labs provide greater profitability by combining different services under one roof.

Office Based Lab Market, By Application

Vascular Surgery
Ophthalmology
Pain Management
Gastroenterology
Orthopedics
Others
Based On Application, The Market is Segmented into Vascular Surgery, Ophthalmology, Pain Management, Gastroenterology, Orthopedics, And Others. Vascular surgeons are the most common service providers in OBLs, with a large percentage of the market. This can be attributable to the country's expanding vascular disease burden. Vascular surgeons undertake all major vascular procedures in office settings, including aortic, mesenteric, kidney, subclavian, iliofemoral, tibial, or pedal.

Office Based Lab Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, The Global Office Based Lab Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Because of the increased proportion of arteriosclerosis in the United States, peripheral vascular treatments (PVI) dominated the Office Based Lab Market by service. Segment growth has also been assisted by a large number of balloon angioplasty and stenting treatments performed in patients with blocked arteries and veins. Nearly 70% of surgical procedures in the United States are conducted in outpatient settings, with around 25% performed in a doctor's office.

Key Players

The "Global Office Based Lab Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Envision Healthcare, TH Medical, MEDNAX Services, Inc., TeamHealth, Medical Facilities Corporation, Surgical Care Affiliates, QHCCS, LLC, Fresenius Medical Care AG & Co. KGaA, Surgery Partners, Medical Facilities Corporation, and others. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

With the acquisition of British minimally invasive device producer BTG for $4.2 billion, Boston Scientific is expected to extend its portfolio of minimally invasive surgical equipment. In November 2018, the two businesses reached an agreement for the acquisition, with Boston Scientific expecting the deal to assist its patient-care strategy.
Cardamoms was purchased for $375 million by St. Jude after it received FDA approval last year. The device is really about the surface area of a paper clip as well as uses Embedded sensors originally capable of monitoring jet engines to remotely monitor a heart failure patient's pulmonary artery tension. St. Jude Medical has been working on an "innovation-based growth strategy" that will enable it to offer a wide range of associated with medical devices to help doctors treat patients with chronic cardiovascular disease.
Boston Scientific purchased a 27 percent stake in Preventive Solutions, a maker of wireless heart-monitoring devices, earlier this year. As a result of the agreement, Boston Sci will be Preventive's official global marketing and sales representative for cardiac patient monitoring products.

1 INTRODUCTION TO GLOBAL OFFICE BASED LAB MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL OFFICE BASED LAB MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL OFFICE BASED LAB MARKET, BY PRODUCT

5.1 Overview
5.2 Single-specialty OBL
5.3 Multi-specialty OBL
5.4 Hybrid

6 GLOBAL OFFICE BASED LAB MARKET, BY APPLICATION

6.1 Overview
6.2 Vascular Surgery
6.3 Ophthalmology
6.4 Pain Management
6.5 Gastroenterology
6.6 Orthopedics
6.7 Others

7 GLOBAL OFFICE BASED LAB MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL OFFICE BASED LAB MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Envision Healthcare
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 TH Medical
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 MEDNAX Services, Inc.
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 TeamHealth
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Medical Facilities Corporation
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Surgical Care Affiliates
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 QHCCS, LLC
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Fresenius Medical Care AG & Co. KGaA
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Surgery Partners
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Medical Facilities Corporation
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments